Email Updates

You are here

Home

Study to evaluate the feasibility of universal HIV testing and ART regardless of CD4 count using the Test and Treat strategy among MSM and transgender women

Status
Ongoing
Phase
Other
Objective

Acceptance of regular HIV testing among HIV-negative MSM/TG and of immeduate ART regardless of CD4 count among newly diagnosed HIV-positive MSM/TG.

Prevention Option(s)
Treatment
Observational
Prospective Cohort
Study Design
Randomized
Arms and Assigned Interventions
Description
All participants receive HIV testing and ART counselling (if tested HIV-positive, regardless of CD4 count). Participants are randomized 4:1 to receive intensive retention strategy (regular communication via social networking tools) or standard retention strategy (telephone call reminder).
ARMs
Experimental
Trial Sponsors
National Research Council, National Security Office, Government Pharmaceutical Organization, Department of Disease Control at the Ministry of Public Health, TREAT Asia, WHO and AIDS fund
January 2012
December 2015
Population
HIV positive
MSM
Sites

Site(s) - Thailand

Thailand